Antineoplastic effect and toxicity of 1,25-dihydroxy-16-ene-23-yne- vitamin D3 in athymic mice with Y-79 human retinoblastoma tumors

Archives of Ophthalmology

Volumn 117, Issue 3, 1999, Pages 365-370

  Sabet, Sina J ^a   Darjatmoko, Soesiawati R ^a   Lindstrom, Mary J ^a   Albert, Daniel M ^a  

^a F4/334 CSC ^*

Author keywords

[No Author keywords available]

Indexed keywords

9,10 SECOCHOLESTA 5,7,10(19),16 TETRAEN 23 YNE 1,3,25 TRIOL; CALCITRIOL; CALCIUM;

ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CALCIUM BLOOD LEVEL; CONTROLLED STUDY; DEATH; DRUG EFFICACY; FEMALE; INTRAPERITONEAL DRUG ADMINISTRATION; LETHARGY; MALE; MORTALITY; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; RETINOBLASTOMA; TUMOR CALCINOSIS; TUMOR GROWTH; TUMOR NECROSIS; TUMOR VOLUME; WEIGHT REDUCTION;

EID: 0033041945     PISSN: 00039950     EISSN: None     Source Type: Journal    
DOI: 10.1001/archopht.117.3.365     Document Type: Article

References (35)

1. Mellanby E. A Story of Nutritional Research: The Effect of Some Nutritional Factors on Bones and the Nervous System. Baltimore, Md: Williams & Wilkins; 1950.
2. Walters M. Newly identified actions of the vitamin D endocrine system. Endocr Rev. 1992;13:719-764.
3. Haussler M. Vitamin D receptors: nature and function. Annu Rev Nutr. 1986;6: 527-562.
4. Schreiner DS, Jande SS, Lawson DE. Target cells of vitamin D in the vertebrate retina, Acta Anat (Basel). 1985;121:153-162.
5. Saulenas AM, Cohen SM, Key LL, Winter C, Albert DM. Vitamin D and retinoblastoma: the presence of receptors and inhibition of growth in vitro. Arch Ophthalmol. 1988;106:533-535.
6. 3 metabolites. Cancer Res. 1983;43:4443-4447.
7. 3 receptors in established human cancer cell lines in culture. Cancer Res, 1982;42:1116-1119.
8. Munker R, Norman A, Koeffler H. Vitamin D compounds: effect on clonal proliferation and differentiation of human myeloid cells. J Clin Invest. 1986;78:424-430.
9. 3 analog with potent ability to induce HL-60 cell differentiation without modulating calcium metabolism. Blood. 1991;78:75-82.
10. Rapoport S. Osmotic opening of blood-brain and blood-ocular barriers. Exp Eye Res. 1977;25(suppl):499-509.
11. Shokravi M, Marcus D, Alroy J, et al. Vitamin D inhibits angiogenesis in transgenic murine retinoblastoma. Invest Ophthalmol Vis Sci. 1995;36:83-87.
12. 3 analogues. Eur J Pharmacol. 1990;178:247-250.
13. 3 analogs: effect on leukemic clonal growth, differentiation, and serum calcium. Leuk Res. 1995;19:65-72.
14. Zhou J, Norman A, Lubbert M, et al. Novel vitamin D analogs that modulate leukemic cell growth and differentiation with little effect on either intestinal calcium absorption or bone calcium mobilization. Blood. 1989;74:82-93.
15. 3 inhibits growth of human breast cancer in vitro and in vivo without causing hypercalcemia. Endocrinology. 1991;129:832-837.
16. 3: differential effects of leukemic cell growth, differentiation, and intestinal calcium absorption. Cancer Res. 1990;50:6857-6864.
17. Munker R, Kobayashi T, Elstner E, et al. A new series of vitamin D analogs is highly active for clonal inhibition, differentiation, and induction of WAF1 in myeloid leukemia. Blood. 1996;88:2201-2209.
18. Verhoeff R. Retinoblastoma undergoing spontaneous regression: calcifying agents suggested in treatment of retinoblastoma. Am J Ophthalmol. 1966;62:573-574.
19. Bullock J, Campbell R, Waller J. Calcification in retinoblastoma. Invest Ophthalmol Vis Sci. 1977;16:252-255.
20. Albert DM, Saulenas AM, Corien SM. Verhoeff's query: is vitamin D effective against retinoblastoma? Arch Ophthalmol. 1988;106:536-540.
21. Cohen SM, Saulenas AM, Sullivan CR, Albert DM. Further studies of the effect of vitamin D on retinoblastoma: inhibition with 1,25-dihydroxycholecalciferol. Arch Ophthalmol. 1988;105:541-543.
22. Shternfeld IS, Lasudry JG, Chappell RJ, Darjatmoko SR, Albert DM. Antineoplastic effect of 1,25-dihydroxy-16-ene-23-yne-vitamin D3 analog in transgenic mice with retinoblastoma. Arch Ophthalmol. 1996;114:1396-1401.
23. 3 in transgenic mice. Clin Cancer Res. 1998;4:2253-2256.
24. Rygaard J, Povlsen C. Heterotransplantation of a human malignant tumor to the mouse mutant nude. Acta Pathol Micmbiol Scand. 1969;77:758-760.
25. Gallie B, Albert D, Wong J, Buyukmihci N, Puliafito C. Heterotransplantation of retinoblastoma into the athymic "nude" mouse. Invest Ophthalmol. 1977;16: 256-259.
26. Pantelouris E. Absence of thymus in a mouse mutant. Nature. 1968;217:370-371.
27. Kleinman H, McGarvey M, Liotta L, et al. Isolation and characterization of type IV collagen, laminin, and heparin sulfate proteoglycan from the EHS sarcoma. Biochemistry. 1982;21:6188-6193.
28. McGuire P, Seeds N. The interaction of plasminogen activator with a reconstituted basement membrane matrix and extracellular macromolecules produced by cultured epithelial cells. J Cell Biochem. 1989;40:215-227.
29. Hadley M, Byers S, Suarez-Quian C, et al. Extracellular matrix regulates Sertoli cell differentiation, testicular cord formation, and germ cell development in vitro. J Cell Biol. 1985;101:1511-1522.
30. Kubota Y, Kleinman H, Martin G, et al. Role of laminin and basement membrane in the morphological differentiation of human endothelial cells into capillary-like structures. J Cell Biol. 1988;107:1589-1598.
31. Medzihradsky F, Marks M. Measures of viability in isolated cells. Biochem Med. 1975;13:164-177.
32. Studzinski GP, McLane JA, Uskokovic MR. Signaling pathways for vitamin D-induced differentiation: implications for therapy of proliferative and neoplastic diseases. Crit Rev Eukaryot Gene Expr. 1993;3:279.
33. Abramson D, Frank C. Second nonocular tumors in survivors of bilateral retinoblastoma. Ophthalmology. 1998;105:573-580.
34. O'Brien J. Alternative treatment in retinoblastoma. Ophthalmology. 1998;105: 571-572.
35. Bornfeld N, Schuler A, Bechrakis N, et al. Preliminary results of primary chemotherapy in retinoblastoma. Klin Padiatr. 1997;209:216-221.